Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster Dose of GSK Pneumococcal Vaccine in Young Adults
NCT00896064Phase 2Completed
- Sponsor
- GSK
- Start
- May 2009
- Primary completion
- Aug 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of GSK 2189242A in pneumococcal infection, sponsored by GSK. Started May 2009; status: completed.
02
Drugs
GSK 2189242A
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00896064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00896064.